With the race on to find a coronavirus vaccine, the biotech sector—from an investor’s point of view—appears to be the new gold rush, promising often giddy returns, but analysts warn that the...
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok